Prospective Assessment in Newborns for Diabetes Autoimmunity

CompletedOBSERVATIONAL
Enrollment

25,055

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Type 1 DiabetesAutoimmunity
Trial Locations (3)

29208

University of South Carolina, Columbia

29425

Medical University of South Carolina, Charleston

32608

University of Florida, Gainesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Florida

OTHER

collaborator

Emory University

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

University of South Carolina

OTHER

lead

Augusta University

OTHER

NCT00649246 - Prospective Assessment in Newborns for Diabetes Autoimmunity | Biotech Hunter | Biotech Hunter